Dalal Z. Husein

1.8k total citations
71 papers, 1.5k citations indexed

About

Dalal Z. Husein is a scholar working on Organic Chemistry, Molecular Biology and Toxicology. According to data from OpenAlex, Dalal Z. Husein has authored 71 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Organic Chemistry, 35 papers in Molecular Biology and 20 papers in Toxicology. Recurrent topics in Dalal Z. Husein's work include Synthesis and biological activity (32 papers), Bioactive Compounds and Antitumor Agents (20 papers) and Angiogenesis and VEGF in Cancer (18 papers). Dalal Z. Husein is often cited by papers focused on Synthesis and biological activity (32 papers), Bioactive Compounds and Antitumor Agents (20 papers) and Angiogenesis and VEGF in Cancer (18 papers). Dalal Z. Husein collaborates with scholars based in Egypt, Saudi Arabia and China. Dalal Z. Husein's co-authors include Reda Hassanien, Mostafa F. Al-Hakkani, Hazem Elkady, Ahmed M. Metwaly, Eslam B. Elkaeed, Ibrahim H. Eissa, Ibrahim M. Ibrahim, Reda G. Yousef, Aisha A. Alsfouk and Tongtong Wang and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Molecules.

In The Last Decade

Dalal Z. Husein

62 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Dalal Z. Husein Egypt	21	635	489	288	197	178	71	1.5k
Sami A. Al‐Hussain Saudi Arabia	22	846 1.3×	369 0.8×	275 1.0×	156 0.8×	38 0.2×	188	1.8k
Mohammad Shahidul Islam Saudi Arabia	25	1.3k 2.0×	300 0.6×	143 0.5×	60 0.3×	144 0.8×	153	1.8k
Umashankar Das Canada	27	1.2k 1.9×	874 1.8×	171 0.6×	430 2.2×	178 1.0×	102	2.6k
Asmaa M. Fahim Egypt	27	1.5k 2.4×	229 0.5×	250 0.9×	31 0.2×	100 0.6×	111	2.3k
Fahad M. Alminderej Saudi Arabia	27	625 1.0×	247 0.5×	259 0.9×	174 0.9×	22 0.1×	94	1.7k
Ali Asadipour Iran	25	1.3k 2.0×	378 0.8×	348 1.2×	427 2.2×	47 0.3×	101	2.5k
Hatem A. Abuelizz Saudi Arabia	21	764 1.2×	366 0.7×	122 0.4×	62 0.3×	36 0.2×	130	1.4k
R. Rahisuddin India	20	507 0.8×	250 0.5×	218 0.8×	124 0.6×	27 0.2×	45	1.2k
Ahmad M. Farag Egypt	29	2.7k 4.2×	376 0.8×	121 0.4×	79 0.4×	140 0.8×	173	3.2k
Peixiao Tang China	25	303 0.5×	672 1.4×	306 1.1×	124 0.6×	21 0.1×	57	1.7k

Countries citing papers authored by Dalal Z. Husein

Since Specialization

Citations

This map shows the geographic impact of Dalal Z. Husein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dalal Z. Husein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dalal Z. Husein more than expected).

Fields of papers citing papers by Dalal Z. Husein

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dalal Z. Husein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dalal Z. Husein. The network helps show where Dalal Z. Husein may publish in the future.

Co-authorship network of co-authors of Dalal Z. Husein

This figure shows the co-authorship network connecting the top 25 collaborators of Dalal Z. Husein. A scholar is included among the top collaborators of Dalal Z. Husein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dalal Z. Husein. Dalal Z. Husein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Elgammal, Walid E., Hazem Elkady, Reda G. Yousef, et al.. (2025). New nicotinamide–thiadiazol hybrids as VEGFR-2 inhibitors for breast cancer therapy: design, synthesis and in silico and in vitro evaluation. RSC Advances. 15(18). 14477–14498. 4 indexed citations

Eissa, Ibrahim H., Alaa Elwan, Dalal Z. Husein, et al.. (2025). Targeting VEGFR-2 in breast cancer: synthesis and in silico and in vitro characterization of quinoxaline-based inhibitors. RSC Advances. 15(17). 12896–12916. 6 indexed citations

Alsfouk, Bshra A., Walid E. Elgammal, Hazem Elkady, et al.. (2025). Integrated computational and biological evaluations of newly synthesized thiadiazole-based VEGFR-2 inhibitors with targeted anti-breast cancer activity. Naunyn-Schmiedeberg s Archives of Pharmacology. 399(1). 953–975.

Yousef, Reda G., Souad A. El‐Metwally, Aisha A. Alsfouk, et al.. (2025). Discovery of new thieno[2,3-d]pyrimidine-based dual VEGFR-2 and EGFR inhibitors for enhanced therapeutic efficacy in breast cancer. Journal of Molecular Structure. 1341. 142586–142586. 1 indexed citations

Elgammal, Walid E., Hazem Elkady, Hazem A. Mahdy, et al.. (2025). 2,3-Dihydro-1,3,4-thiadiazoles as dual B-Raf / VEGFR-2 inhibitors: Design, synthesis, and anti-breast cancer assessment. Journal of Molecular Structure. 1354. 144717–144717.

Elkady, Hazem, Hazem A. Mahdy, Mohammed S. Taghour, et al.. (2024). New thiazolidine-2,4-diones as potential anticancer agents and apoptotic inducers targeting VEGFR-2 kinase: Design, synthesis, in silico and in vitro studies. Biochimica et Biophysica Acta (BBA) - General Subjects. 1868(6). 130599–130599. 13 indexed citations

Eissa, Ibrahim H., Hazem Elkady, Walid E. Elgammal, et al.. (2024). Integrated in silico and in vitro discovery of a new anticancer thiadiazole analog targeting VEGFR-2. Journal of Molecular Structure. 1312. 138641–138641. 13 indexed citations

El‐Metwally, Souad A., Hazem Elkady, Eslam B. Elkaeed, et al.. (2024). New modified thieno[2,3-d]pyrimidine derivatives as VEGFR-2 inhibitors: Design, synthesis, in vitro anti-cancer evaluation and divers in silico studies. Journal of Molecular Structure. 1302. 137465–137465. 7 indexed citations

Eissa, Ibrahim H., Reda G. Yousef, Hazem Elkady, et al.. (2024). Design and In Silico and In Vitro Evaluations of a Novel Nicotinamide Derivative as a VEGFR-2 Inhibitor. Journal of Chemistry. 2024. 1–25. 2 indexed citations

10.

Eissa, Ibrahim H., Walid E. Elgammal, Susi Zara, et al.. (2024). Design, synthesis, and evaluation of novel thiadiazole derivatives as potent VEGFR-2 inhibitors: a comprehensive in vitro and in silico study. RSC Advances. 14(48). 35505–35519. 12 indexed citations

11.

Mahdy, Hazem A., Hazem Elkady, Walid E. Elgammal, et al.. (2024). Design, synthesis, in vitro, and in silico studies of new thiadiazol derivatives as promising VEGFR-2 inhibitors and apoptosis inducers. Journal of Molecular Structure. 1316. 139019–139019. 15 indexed citations

12.

Elkady, Hazem, Mohammed S. Taghour, Mohammed A. Dahab, et al.. (2023). New thiazolidine-2,4-diones as effective anti-proliferative and anti-VEGFR-2 agents: Design, synthesis, in vitro, docking, MD simulations, DFT, ADMET, and toxicity studies. Computational Biology and Chemistry. 107. 107958–107958. 16 indexed citations

13.

El‐Metwally, Souad A., Hazem Elkady, Aly F. Mohamed, et al.. (2023). Discovery of New VEGFR-2 Inhibitors and Apoptosis inducer-based thieno[2,3- d ]pyrimidine. Future Medicinal Chemistry. 15(22). 2065–2086. 6 indexed citations

14.

Elgammal, Walid E., Hazem Elkady, Hazem A. Mahdy, et al.. (2023). Rationale design and synthesis of new apoptotic thiadiazole derivatives targeting VEGFR-2: computational and in vitro studies. RSC Advances. 13(51). 35853–35876. 20 indexed citations

15.

El‐Metwally, Souad A., Hazem Elkady, Mohamed Hagras, et al.. (2023). Design, synthesis, anti-proliferative evaluation, docking, and MD simulation studies of new thieno[2,3-d]pyrimidines targeting VEGFR-2. RSC Advances. 13(33). 23365–23385. 15 indexed citations

16.

Eissa, Ibrahim H., Reda G. Yousef, Hazem Elkady, et al.. (2023). A Theobromine Derivative with Anticancer Properties Targeting VEGFR‐2: Semisynthesis, in silico and in vitro Studies. ChemistryOpen. 12(10). e202300066–e202300066. 11 indexed citations

17.

Eissa, Ibrahim H., Reda G. Yousef, Hazem Elkady, et al.. (2023). New theobromine derivative as apoptotic anti-triple-negative breast cancer targeting EGFR protein: CADD story. Journal of Molecular Structure. 1294. 136336–136336. 36 indexed citations

18.

Taghour, Mohammed S., Hazem Elkady, Wagdy M. Eldehna, et al.. (2022). Design, synthesis, anti-proliferative evaluation, docking, and MD simulations studies of new thiazolidine-2,4-diones targeting VEGFR-2 and apoptosis pathway. PLoS ONE. 17(9). e0272362–e0272362. 40 indexed citations

19.

Husein, Dalal Z., et al.. (2021). Cadmium oxide nanoparticles/graphene composite: synthesis, theoretical insights into reactivity and adsorption study. RSC Advances. 11(43). 27027–27041. 65 indexed citations

20.

Hassanien, Reda, et al.. (2019). Eco‐Friendly Approach to Synthesize Selenium Nanoparticles: Photocatalytic Degradation of Sunset Yellow Azo Dye and Anticancer Activity. ChemistrySelect. 4(31). 9018–9026. 86 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact